Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05810051

Exercise and Coronary Microvascular Disease

Exercise CMD is a prospective single-center, open-label, parallel arms randomized controlled trial.

This trial aims to assess the impact of cardiac rehabilitation on top of optimal medical therapy on patient-reported outcomes in subjects with coronary microvascular disease and non-obstructive coronary artery disease.

Patients will undergo a microvascular assessment using bolus thermodilution techniques and those with criteria for microvascular angina (IMR ≥ 25) will be invited to participate.

Patients will be randomized in a 1:1 ratio to either optimal medical therapy (OMT) or OMT plus a program of cardiac rehabilitations (CR).

After randomization, spiro-ergometry and a SAQ-19 will be performed in all patients. Medical therapy will be standardized in both arms and the CR group will follow 36 sessions of the personalized physical training program of cardiac rehabilitation.

Approximately 204 subjects (102 in each group) will be included at one site (OLV Aalst, Belgium).

Clinical Follow-Up will be planned at 4 months. Patients with CCTA performed in standard of care will be invited for control CCTA 6 +/- 1 month after the invasive procedure.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Coronary Microvascular Disease Angina Pectoris Cardiovascular Diseases Heart Diseases Microvascular Angina Myocardial Ischemia Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

OLV Aalst

Aalst, East-Flanders, 9300, Belgium

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Non obstructive CAD (diameter stenosis <50% visual or FFR > 0.80)
  • Angina at presentation
  • Evidence of microvascular dysfunction (IMR ≥ 25)

Exclusion criteria

  • Inability to give consent
  • Acute coronary syndrome (ACS)
  • Severe valve disease
  • Permanent AF
  • History of coronary artery bypass grafting (CABG)
  • Cardiomyopathies
  • Intolerance to adenosine
  • Hemodynamic instability
  • Not able to exercise

Treatment and study plan

Cardiac rehabilitation

Behavioral

The patients in this arm will be trained for 1 hour, 2 or 3 times per week for 36 sessions. In addition to the training program, the patients also get access to the cardiovascular educational program.

The training (a 1h session) consists of 60% cardiovascular endurance training and 40% resistance training.

Primary outcomes

  1. Mean change in health-related Seattle Angina Questionnaire (SAQ19) between baseline and 4 months

    Time frame: 4 Months

    Mean change in health-related quality of life questionnaire as assessed by the Seattle Angina Questionnaire 19, between baseline and 4 months (SAQ-19 Summary Score) with a maximum score of 100 representing a good quality of life.

Secondary outcomes

  1. Mean change in Seattle Angina Questionnaire (SAQ19)frequency score between baseline and 4 months

    Time frame: 4 Months

    Mean change in the Seattle Angina Questionnaire frequency score between baseline and 4 months with a maximum score of 100 representing no angina symptoms.

  2. Mean change in VO2 peak between baseline and 4 months

    Time frame: 4 Months

    Mean change in exercise capacity, as assessed by the peak oxygen consumption (VO2 peak) derived from spiro-ergometry test between baseline and 4 months

  3. Mean change in VE/VCO2 slope between baseline and 4 months

    Time frame: 4 Months

    Mean change in ventilatory efficiency, as assessed by the VE/VCO2 slope derived from spiro-ergometry test, between baseline and 4 months

  4. Mean change in METS between baseline and 4 months

    Time frame: 4 Months

    Mean change in Metabole equivalents (METS) derived from spiro-ergometry test between baseline and 4 months

  5. Mean change in health related quality of life assessed by the EuroQoL 5 dimensions - 5 levels (EQ5D-5L) Questionnaire between baseline and 4 months

    Time frame: 4 Months

    Mean change in health related quality of life as assessed by the EuroQoL 5 dimensions - 5 levels EQ5D-5L Index score between baseline and 4 months with a score of 1 representing a perfect health condition.

  6. Mean change in vessel volume between patients randomized to exercise and controls

    Time frame: 6 Months

    Mean change in vessel volume as assessed by coronary CT angiography between patients randomized to exercise and controls (only for patients with baseline coronary CT angiography).

Sponsors and collaborators

Lead sponsor

CoreAalst BV

Industry

Collaborators

  • Abbott Medical Devices

Registry information

Official study title

Effects of a Cardiac Rehabilitation Program on Health-related Quality of Life in Patients With Coronary Microvascular Disease.

Acronym: ExerciseCMD

Important dates

Study start
2023
Primary completion
2026
Study completion
2027
First posted
Apr 12, 2023
Registry last updated
Jan 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.